QA: Immuneering Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001790340_2023_Immuneering_Corp.pdf

Logs

Graph

Absolute values for 0001790340, Immuneering Corp

  xvar xval
0 AssetsCurrent 108,746,809
1 IntangibleAssetsNetIncludingGoodwill 7,099,378
2 PropertyPlantAndEquipmentNet 1,369,608
3 remainder_Assets 5,151,488
4 LiabilitiesCurrent 8,054,069
5 LiabilitiesNoncurrent 4,462,959
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 158,122
8 SellingGeneralAndAdministrativeExpense 15,606,529
9 ResearchAndDevelopmentExpense 36,267,116
10 remainder_Expenses 30,053
11 remainder_Revenues 316,952
12 remainder_NetIncome 1,231,300
13 remainder_ComprehensiveNetIncome 18,889
  yvar yval
0 Assets 122,367,283
1 Liabilities 12,517,028
2 Expenses 52,061,820
3 Revenues 316,952
4 StockholdersEquity 109,850,255
5 NetIncome -50,513,568
6 ComprehensiveNetIncome -50,504,124
7 BaseVar 94,256,636
8 EconomicCapitalRatio 2.05

Edgar->Model Mapping

Feature Distribution

Change over Time